LHC Group, Inc. (LHCG) Receives Consensus Rating of “Buy” from Analysts

LHC Group, Inc. (NASDAQ:LHCG) has earned a consensus rating of “Buy” from the fifteen research firms that are currently covering the stock, Marketbeat reports. Four investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $121.30.

LHCG has been the subject of a number of research analyst reports. BidaskClub raised LHC Group from a “buy” rating to a “strong-buy” rating in a report on Friday, May 17th. Zacks Investment Research raised LHC Group from a “sell” rating to a “hold” rating in a report on Saturday, May 11th. Jefferies Financial Group boosted their price target on LHC Group from $125.00 to $130.00 and gave the company a “buy” rating in a report on Thursday, May 9th. Barclays reissued a “hold” rating on shares of LHC Group in a report on Sunday, May 12th. Finally, UBS Group set a $133.00 price target on LHC Group and gave the company a “buy” rating in a report on Friday, May 10th.

In related news, CEO Keith G. Myers sold 75,000 shares of the business’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $108.53, for a total value of $8,139,750.00. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, COO Donald Dwayne Stelly sold 15,151 shares of the business’s stock in a transaction dated Monday, March 11th. The stock was sold at an average price of $107.06, for a total value of $1,622,066.06. Following the completion of the sale, the chief operating officer now owns 92,065 shares in the company, valued at $9,856,478.90. The disclosure for this sale can be found here. Insiders sold 130,324 shares of company stock worth $14,222,700 over the last 90 days. Company insiders own 5.20% of the company’s stock.

Several large investors have recently bought and sold shares of LHCG. Citigroup Inc. grew its position in LHC Group by 265.2% during the 4th quarter. Citigroup Inc. now owns 4,386 shares of the health services provider’s stock worth $412,000 after purchasing an additional 3,185 shares during the period. Everence Capital Management Inc. grew its position in LHC Group by 43.6% during the first quarter. Everence Capital Management Inc. now owns 4,050 shares of the health services provider’s stock valued at $449,000 after purchasing an additional 1,230 shares in the last quarter. Eqis Capital Management Inc. grew its position in LHC Group by 6.2% during the fourth quarter. Eqis Capital Management Inc. now owns 4,837 shares of the health services provider’s stock valued at $454,000 after purchasing an additional 281 shares in the last quarter. Campbell Newman Asset Management Inc. grew its position in LHC Group by 2.4% during the first quarter. Campbell Newman Asset Management Inc. now owns 6,350 shares of the health services provider’s stock valued at $704,000 after purchasing an additional 151 shares in the last quarter. Finally, Financial Gravity Companies Inc. purchased a new position in LHC Group during the fourth quarter valued at approximately $49,000. Institutional investors own 93.88% of the company’s stock.

NASDAQ:LHCG traded down $4.90 during trading hours on Thursday, reaching $113.97. 22,189 shares of the company traded hands, compared to its average volume of 253,604. The stock has a market capitalization of $3.74 billion, a price-to-earnings ratio of 32.11, a PEG ratio of 2.02 and a beta of 0.87. LHC Group has a 1 year low of $73.21 and a 1 year high of $122.20. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.21.

LHC Group (NASDAQ:LHCG) last announced its quarterly earnings data on Wednesday, May 8th. The health services provider reported $0.98 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.90 by $0.08. The business had revenue of $502.59 million during the quarter, compared to analysts’ expectations of $511.16 million. LHC Group had a return on equity of 8.43% and a net margin of 3.83%. As a group, equities research analysts predict that LHC Group will post 4.3 EPS for the current year.

LHC Group Company Profile

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

See Also: Beige Book

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.